Skip to main content
Clinical Trials/ACTRN12619000660189
ACTRN12619000660189
Recruiting
未知

A randomised clinical trial, to evaluate the efficacy of topical dorzolamide for the treatment of idiopathic macular hole

South Australian Institute of Ophthalmology0 sites26 target enrollmentMay 2, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Idiopathic macular hole
Sponsor
South Australian Institute of Ophthalmology
Enrollment
26
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
South Australian Institute of Ophthalmology

Eligibility Criteria

Inclusion Criteria

  • Ability to provide informed consent and complete study assessments
  • Age 18 years or older
  • Idiopathic macular hole in study eye

Exclusion Criteria

  • Renal impairment with creatinine clearance \<30ml/min.
  • Other retinal pathology

Outcomes

Primary Outcomes

Not specified

Similar Trials